Alnylam Pharmaceuticals
ALNY
#656
Rank
$30.36 B
Marketcap
$240.02
Share price
-3.93%
Change (1 day)
18.34%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

Market capitalization of Alnylam Pharmaceuticals (ALNY)

Market cap: $30.36 Billion

As of July 2024 Alnylam Pharmaceuticals has a market cap of $30.36 Billion. This makes Alnylam Pharmaceuticals the world's 656th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Alnylam Pharmaceuticals from 2004 to 2024

End of year Market Cap

Year Market cap Change
2024$30.36 B26.39%
2023$24.02 B-17.84%
2022$29.23 B44.16%
2021$20.28 B34.32%
2020$15.10 B16.87%
2019$12.92 B75.15%
2018$7.37 B-41.45%
2017$12.59 B292.16%
2016$3.21 B-59.89%
2015$8.01 B6.97%
2014$7.48 B82.71%
2013$4.09 B327.85%
2012$0.95 B175.09%
2011$0.34 B-16.59%
2010$0.41 B-43.36%
2009$0.73 B-28.02%
2008$1.02 B-13.62%
2007$1.18 B49.54%
2006$0.79 B207.77%
2005$0.25 B78.85%
2004$0.14 B

End of Day market cap according to different sources

On Jul 17th, 2024 the market cap of Alnylam Pharmaceuticals was reported to be:

$30.36 Billion
by Yahoo Finance info icon info icon
$30.36 Billion
by CompaniesMarketCap info icon info icon
$30.36 Billion
by Nasdaq info icon info icon
$30.39 Billion
by Iex Cloud info icon info icon

Market capitalization for similar companies or competitors

Name Market cap Market cap differencediff. Country
$3.48 B-88.54%๐Ÿ‡บ๐Ÿ‡ธ USA
$119.62 B 294.00%๐Ÿ‡บ๐Ÿ‡ธ USA
$13.88 B-54.26%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.98 B-96.74%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.11 B-99.63%๐Ÿ‡บ๐Ÿ‡ธ USA
$228.11 B 651.36%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
$125.62 B 313.79%๐Ÿ‡ซ๐Ÿ‡ท France
$18.98 B-37.47%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel